Another very interesting and promising development in the world of cancer treatment. Vaxil Bio Therapeutics, a biotechnology company in Israel, has created a vaccine with the potential to prevent the recurrence of 90% of cancers. The vaccine is in clinical trials at Hadassah University Medical Center in Jerusalem and is being administered to patients with multiple myeloma. The new vaccine works by “training” T-cells to search for and destroy cells with the MUC-1 molecule, typically only found in cancer cells. Read about this encouraging development at http://ireport.cnn.com/docs/DOC-732256.
A Cancer Vaccine?
By
